NVE Corporation 10-Q Summary: Quarter Ended June 30, 2008
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for NVE Corporation, a Minnesota-based developer and seller of spintronic devices (nanotechnology using electron spin). The report covers the quarterly period ended June 30, 2008, which represents the first quarter of fiscal year 2009. The company is an accelerated filer with 4,660,083 shares of common stock outstanding as of July 18, 2008.
Key Financial Metrics
| Metric | Q1 FY2009 (Jun 30, 2008) | Q1 FY2008 (Jun 30, 2007) |
|---|---|---|
| Total Revenue | $4,863,786 | $4,709,283 |
| Net Income | $1,902,616 | $1,587,335 |
| Diluted EPS | $0.40 | $0.33 |
| Gross Margin | 71.1% | 69.4% |
| Operating Income | $2,540,838 | $2,194,935 |
| Cash from Operations | $3,519,925 | $1,876,904 |
| Cash & Marketable Securities | $28,156,517 | $24,736,874 (Mar 31, 2008) |
| Total Debt | $0 | $0 |
Note: The company reported no long-term debt or current debt obligations. Total assets were $35.25 million, with shareholders' equity at $33.58 million.
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 3.3% year-over-year. This was driven by a 6.5% increase in product sales (due to new and existing customers) partially offset by a 28.1% decline in contract research and development revenue (due to fewer U.S. Government contract awards).
- Profitability: Net income rose 19.9% to $1.9 million. Gross margin improved to 71.1% due to a favorable revenue mix and higher product margins.
- Expense Reduction: Selling, general, and administrative (SG&A) expenses decreased 6.1% due to lower audit and legal costs. Research and development (R&D) expenses dropped 24.0% following the completion of specific projects.
- Liquidity: Cash and marketable securities increased by approximately $3.4 million compared to the prior quarter, primarily funded by strong operating cash flow. Accounts receivable decreased by $1.17 million due to collections.
Outlook, Risks, and Management Commentary
- Outlook: Management believes working capital is adequate for the next 12 months. They noted that the decrease in R&D expenses may not be representative of future trends, as R&D spending fluctuates based on staffing and project requirements.
- Legal Proceedings: A significant class-action lawsuit filed in 2006 regarding alleged misrepresentations of revenue and technology was dismissed with prejudice by the U.S. District Court in July 2007. This dismissal was affirmed by the U.S. Court of Appeals for the Eighth Circuit on May 30, 2008. Consequently, the company removed the associated risk factor from its disclosures.
- Market Risk: Approximately 75% of total assets are held in marketable securities (government agency, municipal, and corporate obligations). The company does not use derivative financial instruments.
- Accounting Updates: The company is in the process of adopting SFAS No. 157 (Fair Value Measurements) and SFAS No. 162, with no material impact expected on current results.
Key Facts for Investor Verification
- Revenue Mix Shift: Verify the sustainability of product sales growth given the significant drop in government contract R&D revenue.
- R&D Volatility: Confirm future R&D spending plans, as the current quarter's low expense was driven by project completions and may not recur.
- Investment Portfolio: Review the composition of the $26.3 million marketable securities portfolio, which represents the majority of the company's assets and is subject to fair value fluctuations.
- Legal Closure: Confirm that no further appeals or related derivative actions remain that could impact financial results.